FORTAZ: CEFTAZIDIME INJECTION.
The CEFTAZIDIME INJECTION is a the manufacturer industrial component. Key specifications include physical_form: POWDER, administration: INTRAMUSCULAR OR INTRAVENOUS, features_provided: STERILE, primary_container_type: BAG WITH HANGING DEVICE, PLASTIC, supplementary_features: MEDSEP ITEM FOR DOD,GLAXO INC, therapeutic_equivalent: ANY A RATED DRUG. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-231-9931, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| physical_form | POWDER |
| administration | INTRAMUSCULAR OR INTRAVENOUS |
| features_provided | STERILE |
| primary_container_type | BAG WITH HANGING DEVICE, PLASTIC |
| supplementary_features | MEDSEP ITEM FOR DOD,GLAXO INC |
| therapeutic_equivalent | ANY A RATED DRUG |
| protective_storage_feature | FROZEN FOR PRESERVATION |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| total_primary_container_quantity | 24 |
| primary_container_content_quantity | 50.000 MILLILITERS |
| active_medicament_medicinal_strength | 1.00 GRAMS CEFTAZIDIME EQUIVALENT G |
| part_name_assigned_by_controlling_agency | CEFTAZIDIME SODIUM IN DEXTROSE INJECTION 50ML BAG 24S |
| NSN | 6505-01-231-9931 |
| THERAPEUTIC EQUIVALENT | ANY A RATED DRUG |
| ADMINISTRATION | INTRAMUSCULAR OR INTRAVENOUS |
| PRIMARY CONTAINER CONTENT QUANTITY | 500.000 GRAMS G |
| SUPPLEMENTARY FEATURES | MEDSEP ITEM FOR DOD,GLAXO INC |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| FEATURES PROVIDED | STERILE |
| PRIMARY CONTAINER TYPE | VIAL |
| PHYSICAL FORM | POWDER |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | CEFTAZIDIME FOR INJECTION USP 500GM VIAL 25S |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 500.000 GRAMS CEFTAZIDIME, ANHYDROUS EQUIVALENT G |
No substitute or cross-reference records for this part.